Detalhe da pesquisa
1.
Antitumor activity of Z-endoxifen in aromatase inhibitor-sensitive and aromatase inhibitor-resistant estrogen receptor-positive breast cancer.
Breast Cancer Res
; 22(1): 51, 2020 05 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-32430040
2.
The nuclear mitotic apparatus protein NuMA controls rDNA transcription and mediates the nucleolar stress response in a p53-independent manner.
Nucleic Acids Res
; 45(20): 11725-11742, 2017 Nov 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-28981686
3.
NuMA promotes homologous recombination repair by regulating the accumulation of the ISWI ATPase SNF2h at DNA breaks.
Nucleic Acids Res
; 42(10): 6365-79, 2014 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-24753406
4.
Endoxifen downregulates AKT phosphorylation through protein kinase C beta 1 inhibition in ERα+ breast cancer.
NPJ Breast Cancer
; 9(1): 101, 2023 12 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-38114522
5.
Endoxifen, an Estrogen Receptor Targeted Therapy: From Bench to Bedside.
Endocrinology
; 162(12)2021 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34480554
6.
CITED2 attenuates macrophage recruitment concordant with the downregulation of CCL20 in breast cancer cells.
Oncol Lett
; 15(1): 871-878, 2018 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-29399152
7.
Label-free Raman spectroscopy provides early determination and precise localization of breast cancer-colonized bone alterations.
Chem Sci
; 9(3): 743-753, 2018 Jan 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-29629144
8.
Down-regulation of CITED2 attenuates breast tumor growth, vessel formation and TGF-ß-induced expression of VEGFA.
Oncotarget
; 8(4): 6169-6178, 2017 Jan 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-28008154
9.
CITED2 Modulates Breast Cancer Metastatic Ability through Effects on IKKα.
Mol Cancer Res
; 14(8): 730-9, 2016 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-27216153
10.
CCL20/CCR6 Signaling Regulates Bone Mass Accrual in Mice.
J Bone Miner Res
; 31(7): 1381-90, 2016 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-26890063